Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness. | Int J Mol Sci | 2025 | 41226794 | PubTator, text mining | PubMed |
| Immune cell dynamics and prognostic role of M2 macrophages and LDOC1 in colon adenocarcinoma. | Discov Oncol | 2025 | 41105192 | PubTator, text mining | PubMed |
| A hybrid extended Fermatean fuzzy WASPAS approach for optimal blockchain selection in building information modelling. | Sci Rep | 2025 | 41093999 | PubTator, text mining | PubMed |
| Abstracts from the 33rd Portuguese Dental Association Annual Meeting. | BMC Proc | 2025 | 41053802 | PubTator, text mining | PubMed |
| Coping behavior toward occupational health risks among construction workers: determinant identification using the COM-B model and data mining analysis. | Front Public Health | 2025 | 41018795 | PubTator, text mining | PubMed |
Fault Diagnosis of a Bogie Gearbox Based on Pied Kingfisher Optimizer-Improved Complete Ensemble Empirical Mode Decomposition with Adaptive Noise, Improved Multi-Scale Weighted Permutation Entropy, and Starfish Optimization Algorithm-Least-Squares Support Vector Machine. | Entropy (Basel) | 2025 | 41008031 | PubTator, text mining | PubMed |
| Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives. | Nat Rev Neurol | 2025 | 40983775 | PubTator, text mining | PubMed |
| Delineating the pathogenic threshold and phenotypic spectrum of SCA27B: findings from a large French-Canadian cohort. | J Neurol | 2025 | 40974444 | PubTator, text mining | PubMed |
| Identification of novel Piperazine based bisubstrate inhibitors of human nicotinamide N-methyltransferase (hNNMT) with potential anticancer activities. | Bioorg Med Chem | 2025 | 40961781 | PubTator, text mining | PubMed |
| Discovery of RNA-Reactive Small Molecules Guides the Design of Electrophilic Modules for RNA-Specific Covalent Binders. | J Am Chem Soc | 2025 | 40951988 | PubTator, text mining | PubMed |
| Development of an AAV-delivered microRNA gene therapy for myotonic dystrophy type 1. | Mol Ther | 2025 | 40903903 | PubTator, text mining | PubMed |
| circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1. | Mol Ther Nucleic Acids | 2025 | 40896579 | PubTator, text mining | PubMed |
| Epidemiological report and diagnostic approach used in the neuromuscular population of Liege, Belgium. | Orphanet J Rare Dis | 2025 | 40883749 | PubTator, text mining | PubMed |
| Measuring Myotonia: Normative Values and Comparison with Myotonic Dystrophy Type 1. | Neurol Int | 2025 | 40863987 | PubTator, text mining | PubMed |
| Discovery of RNA-Targeting Small Molecules: Challenges and Future Directions. | MedComm (2020) | 2025 | 40859960 | PubTator, text mining | PubMed |
| Pilomatricoma in Syndromic Contexts: A Literature Review and a Report of a Case in Apert Syndrome. | Dermatopathology (Basel) | 2025 | 40843798 | PubTator, text mining | PubMed |
| Novel Inhibitors of Plasmodium Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and In Vivo Efficacy in a Humanized Mouse Malaria Infection Model. | J Med Chem | 2025 | 40811478 | PubTator, text mining | PubMed |
| The blind men and the elephant: recognising the multisystem symptoms of myotonic dystrophy type 1. | Orphanet J Rare Dis | 2025 | 40804685 | PubTator, text mining | PubMed |
| Transcriptome alterations underlying metabolic dysfunction and liver disease in myotonic dystrophy type 1. | Hum Mol Genet | 2025 | 40801161 | PubTator, text mining | PubMed |
| Novel β-carboline derivatives show promise as dual-target inhibitors of DNA and TOP2A for the treatment of triple negative breast cancer. | Eur J Med Chem | 2025 | 40779814 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers?page=5